Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
lidocaine (xylocaine) (1 trial)
pf-06650833 (1 trial)
rilpivirine (edurant) (1 trial)
tenofovir (viread) (1 trial)
bupivacaine (Exparel) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 2)
Hepatitis B (Phase 2)
Hepatitis B, Chronic (Phase 2)
HIV Infections (Phase 2)
Trials (5 total)
Trial APIs (5 total)